🔎 Trials Near Me

Gara Jalqabaatti › Leukemia Myeloidii Hamaa › New Jersey › Edison

Qorannoo klinikaalii Leukemia Myeloidii Hamaa Edison, NJ keessatti

Qorannoo 20 Leukemia Myeloidii Hamaa f Edison fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Namoota walitti qabaa jiraSadarkaa 1
  • Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06484062

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · Miili 15 fagaatti
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06317649

A Study of CRD3874-SI in People With Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07661095

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · Miili 15 fagaatti
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Namoota walitti qabaa jiraSadarkaa 3
  • Saint Peter's University Hospital, New Brunswick · Miili 3 fagaatti
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · Miili 3 fagaatti
6 Months – 21 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT04293562

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Namoota walitti qabaa jiraSadarkaa 1/2
  • Saint Peter's University Hospital, New Brunswick · Miili 3 fagaatti
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · Miili 3 fagaatti
Hanga umuriin 22 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04726241

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Namoota walitti qabaa jiraSadarkaa 3
  • Rutgers Biomedical and Health Sciences, New Brunswick · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT07007312

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 2
  • Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · Miili 15 fagaatti
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 17-Ado-2026 · NCT07392242

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT01351545

A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT05756777

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · Miili 15 fagaatti
Umuriin 1 fi ol · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT06017258

A Study of Revumenib and Mezigdomide in People With Leukemia

Namoota walitti qabaa jiraSadarkaa 1/2
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · Miili 15 fagaatti
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT07356154

A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · Miili 15 fagaatti
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT07011004

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 24-Bit-2026 · NCT04988555

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Namoota walitti qabaa jiraSadarkaa 1
  • Rutgers Cancer Institute, New Brunswick · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT05735184

A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Bit-2026 · NCT05748197

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Gur-2026 · NCT06773208

Qorannoo Leukemia Myeloidii Hamaa magaalota biroo keessatti

Qorannoo biroo Edison keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.